Log on / register
Feedback | Support

Pre-publication history

Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B

Jennifer M Reynolds* email, Kamal El Bissati* email, Jens Brandenburg email, Arthur Günzl email and Choukri Ben Mamoun email

BMC Clinical Pharmacology 2007, 7:13doi:10.1186/1472-6904-7-13

Pre-publication versions of this article and reviewers' reports

Original submission - Version 5Manuscript01 Aug 2007
Reviewer's ReportWalther Wernsdorfer21 Aug 2007
Reviewer's ReportKathy Andrews28 Aug 2007
Resubmission - Version 6ManuscriptAuthors' comments18 Sep 2007
Resubmission - Version 7ManuscriptAuthors' comments18 Oct 2007
Resubmission - Version 8ManuscriptAuthors' comments22 Oct 2007
Resubmission - Version 9Manuscript23 Oct 2007
Accepted23 Oct 2007
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated